Cargando…
Intractable problems require novel solutions: it's time to get serious about developing a gonorrhoea vaccine
Autores principales: | Semchenko, Evgeny A, Seib, Kate L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256376/ https://www.ncbi.nlm.nih.gov/pubmed/27037185 http://dx.doi.org/10.1136/sextrans-2015-052378 |
Ejemplares similares
-
Outer membrane vesicle vaccines for Neisseria gonorrhoeae
por: Semchenko, Evgeny A., et al.
Publicado: (2021) -
The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019) -
The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells
por: Semchenko, Evgeny A., et al.
Publicado: (2020) -
MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies
por: Semchenko, Evgeny A., et al.
Publicado: (2017) -
The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate
por: Jen, Freda E.-C., et al.
Publicado: (2019)